Global Actigraphs Market Size, Share and Trends Analysis Report – Industry Overview and Forecast to 2033

Global Actigraphs Market Segmentation, By Product Type (Watch and Fitbit), Indication (Sleep Apnea, Insomnia, Narcolepsy, Restless Leg Syndrome, Rapid Eye Movement Behaviour Disorder, Delayed Sleep Phase Syndrome and Sleepwalking), Application (Sleep Medicine, Sleep Disorder, Circadian Rhythm Disorder and Daytime Activity Research), Technology Type (USB, Wireless Technology, GPS and Others), Distribution Channel (Retail Stores, Pharmacies, Online Retail Stores, Hospitals, Homecare Settings and Diagnostic Laboratories)- Industry Trends and Forecast to 2033

Actigraphs Market Size

• The global actigraphs market size was valued at USD 1.62 billion in 2025 and is expected to reach USD 2.45 billion by 2033, at a CAGR of 5.35% during the forecast period
• The market growth is largely fueled by the rising prevalence of sleep disorders, increasing awareness of sleep health, and the growing adoption of wearable and connected health monitoring devices
• Furthermore, demand for accurate, non-invasive, and user-friendly activity and sleep tracking solutions is driving the adoption of actigraphs in both clinical and research settings. These converging factors are accelerating the uptake of actigraphy devices, thereby significantly boosting the industry's growth

Actigraphs Market Analysis

• Actigraphs, which are wearable or portable devices used to monitor physical activity and sleep–wake patterns, are increasingly utilized in sleep medicine, circadian rhythm studies, and daytime activity research due to their non-invasive design, continuous monitoring capability, and suitability for long-term data collection
• The growing demand for actigraphs is primarily driven by the rising prevalence of sleep-related disorders such as sleep apnea and insomnia, increasing awareness of sleep health, and the expanding use of wearable technologies in clinical diagnostics and research applications
• North America dominated the global actigraphs market with a revenue share of 39.9% in 2025, supported by advanced healthcare infrastructure, strong adoption of digital health technologies, and extensive research activities in sleep medicine, with the U.S. witnessing significant usage across hospitals, diagnostic laboratories, and sleep research centers
• Asia-Pacific is expected to be the fastest growing region in the actigraphs market during the forecast period due to improving healthcare infrastructure, increasing diagnosis rates of sleep disorders, and growing adoption of wearable health monitoring devices across emerging economies
• The watch segment dominated the market with a share of 62.6% in 2025, driven by ease of use, patient comfort, continuous monitoring capability, and widespread adoption across sleep apnea, insomnia, and circadian rhythm disorder applications

Report Scope and Actigraphs Market Segmentation  

Actigraphs Market Trends

Integration of Wireless Connectivity and Advanced Data Analytics

• A significant and accelerating trend in the global actigraphs market is the increasing integration of wireless technologies and advanced data analytics platforms, enabling seamless data transfer, real-time monitoring, and improved clinical decision-making across healthcare and research environments

  • For instance, modern wireless actigraph devices allow clinicians and researchers to remotely access patient sleep and activity data without physical retrieval, significantly improving monitoring efficiency in sleep studies and long-term observational research

• Advanced analytics integration enables actigraphs to deliver more precise insights into sleep patterns, circadian rhythm disruptions, and daytime activity behaviors, supporting improved diagnosis and treatment planning for sleep-related disorders
• The seamless connectivity of actigraphs with digital health platforms and electronic health records allows centralized data management, enabling clinicians to correlate actigraphy data with other diagnostic parameters for comprehensive patient assessment
• This trend toward smarter, connected, and data-driven actigraphy solutions is reshaping expectations in sleep diagnostics and research workflows, prompting manufacturers to enhance device intelligence and interoperability
• Consequently, companies are increasingly developing wireless and cloud-enabled actigraphs with automated data analysis capabilities to meet growing demand from hospitals, diagnostic laboratories, and clinical research organizations

Actigraphs Market Dynamics

Driver

Rising Prevalence of Sleep Disorders and Demand for Objective Diagnostics

• The increasing prevalence of sleep-related disorders such as sleep apnea, insomnia, and circadian rhythm disorders, combined with the growing need for objective diagnostic tools, is a major driver fueling demand for actigraphs globally

  • For instance, healthcare providers are increasingly adopting actigraphy as a non-invasive alternative to polysomnography for long-term sleep monitoring, particularly in outpatient and homecare settings

• As awareness of sleep health grows among patients and clinicians, actigraphs provide continuous, real-world data that enhances diagnostic accuracy and supports personalized treatment approache
• Furthermore, the expansion of sleep medicine services and clinical research studies is increasing reliance on actigraph devices for longitudinal data collection and patient compliance monitoring
• The growing emphasis on preventive healthcare and early diagnosis is further driving the use of actigraphs for long-term monitoring of sleep patterns before disorders progress to severe clinical stages
• Moreover, increasing utilization of actigraphy in pharmaceutical and academic research studies is strengthening demand, as researchers seek reliable, cost-effective tools for large-scale and longitudinal sleep data collection
• The growing integration of wearable health technologies into routine clinical practice, along with rising acceptance of remote monitoring solutions, is significantly propelling actigraph adoption across healthcare systems

Restraint/Challenge

Data Accuracy Limitations and Regulatory Compliance Constraint

• Concerns related to data accuracy, interpretation variability, and limitations in distinguishing between certain sleep stages pose challenges to the broader adoption of actigraphs in clinical diagnostics

  • For instance, actigraphs may sometimes misclassify quiet wakefulness as sleep, leading clinicians to rely on complementary diagnostic tools for confirmation in complex cases

• In addition, stringent regulatory requirements for medical-grade devices can slow product approvals and increase development costs for manufacturers operating across multiple regions
• The need for standardized validation protocols and clinical guidelines further complicates market expansion, particularly in emerging economies with evolving regulatory frameworks
• Addressing these challenges through improved sensor technology, validated algorithms, clinician training, and regulatory alignment will be critical for sustaining long-term growth in the global actigraphs market
• Limited awareness and understanding of actigraphy technology among general practitioners in certain regions can restrict adoption, particularly where polysomnography remains the default diagnostic standard
• Furthermore, interoperability challenges between actigraph devices and existing hospital IT systems may hinder seamless data integration, slowing adoption in facilities with legacy infrastructure

Actigraphs Market Scope

The market is segmented on the basis of product type, indication, application, technology type, and distribution channel.

• By Product Type

on the basis of product type, the global actigraphs market is segmented into watch and fitbit. The watch-based actigraphs segment dominated the market in 2025 with a market share of 62.6%, driven by their clinical-grade accuracy, long battery life, and widespread acceptance in sleep medicine and research environments. Watch-based devices are extensively used in hospitals, diagnostic laboratories, and clinical trials due to their validated algorithms and ability to collect continuous longitudinal data. Their compatibility with specialized sleep analysis software further strengthens their dominance. In addition, watch-based actigraphs are preferred for regulated medical applications, where data reliability and standardization are critical.

The Fitbit-based actigraphs segment is expected to witness the fastest growth during the forecast period, fueled by increasing adoption of consumer wearables in healthcare monitoring and research studies. Fitbit devices offer cost-effective solutions, ease of use, and growing acceptance in large-scale population studies and home-based sleep assessments. Their integration with mobile health applications and cloud-based analytics platforms supports rapid data collection and remote monitoring. The growing convergence of consumer wearables with clinical research is accelerating the adoption of Fitbit-based actigraphy solutions.

• By Indication

On the basis of indication, the actigraphs market is segmented into sleep apnea, insomnia, narcolepsy, restless leg syndrome, rapid eye movement behaviour disorder, delayed sleep phase syndrome, and sleepwalking. The insomnia segment dominated the market in 2025, owing to the high global prevalence of insomnia and the increasing reliance on actigraphy for long-term sleep–wake pattern assessment. Actigraphs are widely used to monitor sleep duration, fragmentation, and circadian disruptions in insomnia patients, particularly in outpatient and homecare settings. The non-invasive nature of actigraphy makes it suitable for repeated and prolonged monitoring, supporting its dominant position. Rising awareness of sleep health and behavioral sleep interventions further reinforces this segment’s leadership.

The sleep apnea segment is expected to be the fastest growing during the forecast period, driven by increasing diagnosis rates and the growing use of actigraphy as a complementary tool to polysomnography. Actigraphs are increasingly utilized to assess sleep patterns, treatment compliance, and daytime activity in sleep apnea patients. The expansion of home sleep testing and remote patient monitoring is accelerating demand within this indication. Growing investments in sleep clinics and digital diagnostics further support rapid growth in this segment.

• By Application

On the basis of application, the market is segmented into sleep medicine, sleep disorder, circadian rhythm disorder, and daytime activity research. The sleep medicine segment held the largest market share in 2025, supported by widespread use of actigraphs in clinical diagnosis, treatment monitoring, and follow-up care for sleep-related conditions. Actigraphy is increasingly incorporated into routine sleep assessments due to its ability to provide objective, real-world sleep data over extended periods. Hospitals and sleep clinics rely on actigraphs to complement traditional diagnostic tools, strengthening this segment’s dominance. Growing demand for non-invasive diagnostics continues to drive adoption.

The circadian rhythm disorder segment is anticipated to grow at the fastest rate during the forecast period, driven by increasing recognition of circadian misalignment in shift workers, adolescents, and aging populations. Actigraphs play a critical role in identifying circadian phase delays and irregular sleep–wake cycles. Rising research activity and clinical focus on circadian health are accelerating adoption. The use of actigraphy in light therapy and behavioral interventions further supports growth in this application segment.

• By Technology Type

On the basis of technology type, the global actigraphs market is segmented into usb, wireless technology, GPS, and others. The wireless technology segment dominated the market in 2025, driven by the growing demand for real-time data transmission, remote monitoring, and improved patient convenience. Wireless actigraphs eliminate the need for physical data retrieval, enhancing workflow efficiency in hospitals and research environments. Their integration with cloud-based platforms and electronic health records further strengthens adoption. The increasing shift toward digital health ecosystems supports continued dominance.

The GPS-enabled actigraphs segment is expected to witness the fastest growth during the forecast period, driven by rising interest in location-based activity monitoring and mobility analysis. GPS technology enhances actigraphy data by providing contextual insights into outdoor activity, travel patterns, and lifestyle behaviors. This is particularly valuable in research studies and advanced sleep and activity analysis. Growing adoption in behavioral research and population health studies is accelerating growth in this segment.

• By Distribution Channel

On the basis of distribution channel, the actigraphs market is segmented into retail stores, pharmacies, online retail stores, hospitals, homecare settings, and diagnostic laboratories. The hospitals segment dominated the market in 2025, owing to the high volume of sleep diagnostics, inpatient monitoring, and clinical research activities conducted in hospital settings. Hospitals rely on medical-grade actigraphs for diagnostic accuracy, treatment monitoring, and integration with other clinical systems. The presence of trained professionals and standardized diagnostic protocols further supports dominance. Increasing investments in sleep medicine departments are reinforcing this trend.

The homecare settings segment is expected to grow at the fastest rate during the forecast period, driven by the rising shift toward remote patient monitoring and home-based sleep diagnostics. Actigraphs are increasingly prescribed for long-term monitoring outside clinical environments, improving patient comfort and compliance. Advancements in wireless connectivity and wearable design are enabling wider adoption in homecare. The growing focus on decentralized healthcare delivery is significantly accelerating growth in this distribution channel.

Actigraphs Market Regional Analysis

• North America dominated the global actigraphs market with a revenue share of 39.9% in 2025, supported by advanced healthcare infrastructure, strong adoption of digital health technologies, and extensive research activities in sleep medicine, with the U.S. witnessing significant usage across hospitals, diagnostic laboratories, and sleep research centers
• Healthcare providers and research institutions in the region highly value the clinical accuracy, non-invasive monitoring capabilities, and long-term data collection offered by actigraphs for sleep and activity analysis
• This widespread adoption is further supported by high healthcare expenditure, a strong focus on digital health innovation, and extensive clinical research activity, establishing actigraphs as a preferred solution across hospitals, diagnostic laboratories, and sleep research centers

U.S. Actigraphs Market Insight

The U.S. actigraphs market captured the largest revenue share within North America in 2025, driven by the widespread adoption of sleep monitoring technologies and strong demand from hospitals, sleep clinics, and research institutions. Healthcare providers increasingly prioritize objective, non-invasive tools for long-term sleep and activity assessment. The growing prevalence of sleep disorders, combined with high healthcare spending and early adoption of digital health solutions, continues to propel market growth. Moreover, extensive clinical research activity and the integration of actigraphy into clinical trials are significantly contributing to the expansion of the U.S. actigraphs market.

Europe Actigraphs Market Insight

The Europe actigraphs market is projected to expand at a steady CAGR throughout the forecast period, primarily driven by increasing awareness of sleep health and rising diagnosis rates of sleep-related disorders. Growing emphasis on preventive healthcare and standardized clinical practices is fostering the adoption of actigraphs across hospitals and diagnostic laboratories. European healthcare systems are increasingly incorporating actigraphy into sleep medicine and circadian rhythm research. The region is witnessing consistent growth across clinical, research, and homecare applications, supported by favorable healthcare policies and technological advancements.

U.K. Actigraphs Market Insight

The U.K. actigraphs market is anticipated to grow at a notable CAGR during the forecast period, supported by expanding sleep research initiatives and rising adoption of wearable health monitoring devices. Increasing awareness of insomnia and circadian rhythm disorders is encouraging healthcare providers to adopt actigraphy for long-term monitoring. The country’s strong academic and clinical research infrastructure further supports market growth. In addition, the integration of digital health technologies within the National Health Service is expected to sustain demand for actigraph devices.

Germany Actigraphs Market Insight

The Germany actigraphs market is expected to expand at a considerable CAGR during the forecast period, driven by strong focus on clinical accuracy, research excellence, and technology-driven healthcare solutions. Germany’s well-established healthcare infrastructure and emphasis on evidence-based diagnostics support the adoption of actigraphy in sleep medicine. Growing research activity related to circadian rhythm disorders and neurological conditions further boosts demand. The preference for high-quality, validated medical devices aligns well with actigraph adoption across clinical and research settings.

Asia-Pacific Actigraphs Market Insight

The Asia-Pacific actigraphs market is poised to grow at the fastest CAGR during the forecast period, driven by improving healthcare infrastructure, rising awareness of sleep disorders, and increasing adoption of wearable health technologies. Countries such as China, Japan, and India are witnessing rapid growth in sleep medicine services and diagnostic capabilities. Government initiatives supporting digital healthcare and growing investments in medical research are accelerating market expansion. In addition, the increasing availability of cost-effective actigraph solutions is expanding adoption across the region.

Japan Actigraphs Market Insight

The Japan actigraphs market is gaining momentum due to the country’s advanced healthcare system, strong research culture, and growing focus on sleep health. Actigraph adoption is driven by increasing diagnosis of sleep disorders and the integration of wearable monitoring technologies into clinical practice. Japan’s aging population is further contributing to demand for long-term, non-invasive sleep and activity monitoring solutions. Moreover, the country’s emphasis on precision diagnostics and digital health innovation continues to support market growth.

India Actigraphs Market Insight

The India actigraphs market accounted for a significant revenue share within Asia-Pacific in 2025, supported by rapid urbanization, growing healthcare awareness, and increasing diagnosis of sleep-related disorders. India is emerging as a key market for wearable health monitoring devices, with actigraphs gaining traction in hospitals, diagnostic laboratories, and research institutions. The expansion of sleep clinics and rising investment in digital healthcare infrastructure are key growth drivers. In addition, increasing affordability and domestic manufacturing capabilities are further propelling the actigraphs market in India.

Actigraphs Market Share

The Actigraphs industry is primarily led by well-established companies, including:

• ActivInsights Ltd (U.K.)
• Axivity Ltd (U.K.)
• CamNtech Ltd and CamNtech Inc (U.K.)
• McRoberts (Netherlands)
• Empatica Inc (U.S.)
• movisens GmbH (Germany)
• Shimmer Sensing Ltd (Ireland)
• SOMNOmedics GmbH (Germany)
• Compumedics Limited (Australia)
• ResMed Inc. (U.S.)
• Natus Medical Incorporated (U.S.)
• Nox Medical (Iceland)
• BMC Medical Co., Ltd (China)
• Wearable Sensing, Inc. (U.S.)
• Bitbrain Technologies SL (Spain)
• Condor Instruments Ltd (U.K.)
• Polar Electro Oy (Finland)
• Ametris (U.S.)

What are the Recent Developments in Global Actigraphs Market?

• In May 2025, ActiGraph partnered with ZEPHYRx to integrate respiratory digital endpoints with actigraphy-based activity and sleep metrics within a single clinical research platform. The collaboration enables synchronized collection of respiratory function data and continuous actigraphy data, improving the assessment of treatment outcomes in respiratory and cardiopulmonary clinical trials. This development reflects the increasing demand for integrated, objective digital biomarkers in clinical research
• In January 2025, ActiGraph announced the acquisition of Biofourmis Connect, a division of Biofourmis focused on life sciences and clinical research solutions. This strategic move aims to create a unified, end-to-end digital research ecosystem by combining Biofourmis’ AI-driven analytics and digital trial capabilities with ActiGraph’s medical-grade wearable and actigraphy expertise. The acquisition strengthens ActiGraph’s ability to support decentralized and hybrid clinical trials, enabling continuous, real-world data capture across the drug development lifecycle
• In January 2025, ActiGraph and Hyfe, Inc. announced the launch of an integrated digital health solution combining Hyfe’s AI-powered cough detection technology with the ActiGraph LEAP™ wearable platform. This collaboration enables continuous, passive monitoring of cough frequency alongside sleep, physical activity, and other physiological parameters in clinical trials. The solution is particularly valuable for respiratory and chronic disease research, where objective, real-time symptom tracking is critical
• In November 2023, ActiGraph launched ActiGraph LEAP™, a next-generation multisensor wearable designed specifically for clinical research applications. The device is capable of capturing physical activity, sleep, mobility, heart rate, and other digital health measures in a single platform. LEAP™ represents a significant advancement in actigraphy technology, offering improved data accuracy, longer wear time, and enhanced participant comfort
• In January 2021, ActiGraph partnered with VeraSci to expand the use of medical-grade wearable technology, including the CentrePoint Insight Watch, in NIH-funded clinical studies. The collaboration focused on integrating actigraphy and gait metrics with cognitive and functional outcome measures, particularly in Alzheimer’s disease research. This partnership highlighted the growing acceptance of actigraphy as a reliable source of objective, real-world data in neurological and aging-related studies

SKU-50323